Millendo Therapeutics acquires French biopharmaceutical company
Millendo Therapeutics acquires Alize Pharma in stock-based transaction Merger beefs up Millendo's congenital adrenal hyperplasia program Alize Pharma is known for developing treatment for Prader-Willi syndrome Millendo Therapeutics Inc. has acquired Alizé Pharma SAS in a stock-based transaction, the Ann Arbor-based biopharmaceutical company announced Wednesday. The deal includes Alizé Pharma's facilities, operations and staff, which will handle research and development. Alize